Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06256718 · ClinicalTrials.gov registry record · NA
Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care
A NA study of Human Papillomavirus Infection, sponsored by Roswell Park Cancer Institute.
- Active
- Registry status
- NA
- Development phase
- 203
- Enrollment target
- 1
- Study location
NCT06256718 is a NA study of Human Papillomavirus Infection that is active but no longer recruiting, run by Roswell Park Cancer Institute. The registered enrollment target is 203 participants, below the 1,307-participant average among 17 other Human Papillomavirus Infection trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06256718, a NA study of Human Papillomavirus Infection, is active but no longer recruiting, sponsored by Roswell Park Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 203 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the implementation of evidence based strategies to optimize HPV vaccination in rural primary care settings. Some of the largest disparities in human papillomavirus vaccination (HPVV) rates exist in rural communities, which represent missed opportunities for cancer prevention. Primary care provider visits in these communities serve as a crucial opportunity to communicate the importance of timely vaccination that is essential to effective cancer prevention. This study implements and tests a practice-level intervention (PC TEACH) using practice facilitation of evidence-based strategies to expand reach to rural community-based primary care settings to optimize delivery and increase HPVV rates. PC TEACH program may help rural communities overcome access and awareness factors that keep them from receiving HPVV.
Conditions Studied
Interventions
- OTHER Educational Intervention
Study Locations (1)
New York
- Roswell Park Cancer Institute - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2023-05-24 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06256718
The ClinicalTrials.gov registry entry for NCT06256718 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,307-participant average among 17 other Human Papillomavirus Infection trials with a reported enrollment target (84% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Human Papillomavirus Infection appearing as the primary indexed condition, and to 1 intervention - of which Educational Intervention is the first listed.
NCT06256718 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06256718 about?
NCT06256718 is a clinical study titled "Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care". This study evaluates the implementation of evidence based strategies to optimize HPV vaccination in rural primary care settings. Some of the largest disparities in human papillomavirus vaccination (HPVV) rates exist in rural communities, which represent missed opportunities for cancer prevention. Pr...
What is the current status of trial NCT06256718?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 203 participants. The study started on 2023-05-24. Estimated completion is 2027-04-30.
What conditions does trial NCT06256718 study?
This clinical trial studies the following conditions: Human Papillomavirus Infection.
What interventions are being tested in trial NCT06256718?
The interventions under investigation include: Educational Intervention (OTHER).
Who is sponsoring clinical trial NCT06256718?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06256718 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papillomavirus Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
RECRUITING · NA
-
Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy
RECRUITING · NA
-
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
ACTIVE NOT RECRUITING · NA
-
Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.